Literature DB >> 3089403

Irreversible pulmonary hypertension after treatment with fenfluramine.

J McMurray, P Bloomfield, H C Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3089403      PMCID： PMC1340807          DOI： 10.1136/bmj.293.6538.51-d

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

2.  Irreversible pulmonary hypertension after treatment with fenfluramine.

Authors:  J McMurray; P Bloomfield; H C Miller
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

Review 3.  Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.

Authors:  J D Hughes; L J Rubin
Journal:  Medicine (Baltimore)       Date:  1986-01       Impact factor: 1.889

4.  [A case of chronic pulmonary hypertension after fenfluramine intake].

Authors:  G Gaul; G Blazek; E Deutsch; H Heeger
Journal:  Wien Klin Wochenschr       Date:  1982-11-26       Impact factor: 1.704

5.  Pulmonary hypertension and fenfluramine.

Authors:  J G Douglas; J F Munro; A H Kitchin; A L Muir; A T Proudfoot
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-03
  5 in total
  1 in total

1.  The Triple Combination Phentermine Plus 5-HTP/Carbidopa Leads to Greater Weight Loss, With Fewer Psychomotor Side Effects Than Each Drug Alone.

Authors:  Claudia I Perez; B Kalyanasundar; Mario G Moreno; Ranier Gutierrez
Journal:  Front Pharmacol       Date:  2019-11-06       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.